Navigation Links
BRAVE-3 Questions Value of Abciximab in PCI for Heart Attack
Date:3/30/2008

With high-dose clopidogrel, the intravenous anti-platelet drug appears

unnecessary

CHICAGO, March 30 /PRNewswire/ -- Over the years, interventional cardiologists have made many improvements in percutaneous coronary intervention (PCI) for patients with heart attack, among the most important, refinements in the selection and administration of drugs that prevent unwanted blood clotting. Now a new study has found that high loading doses of clopidogrel, an oral medication that inhibits blood clots by preventing platelets from clumping together, can eliminate the need for intravenous abciximab, a standard cath-lab drug that also interferes with platelets, but through a different pathway.

The BRAVE-3 study is the first to test the influence of high-dose clopidogrel on the value of abciximab exclusively in patients with ST-elevation myocardial infarction (STEMI), a serious form of heart attack. The study is being reported today in a Late-Breaking Clinical Trials session at the SCAI Annual Scientific Sessions in Partnership with ACC i2 Summit (SCAI-ACCi2) in Chicago. SCAI-ACCi2 is a scientific meeting for practicing cardiovascular interventionalists sponsored by the Society for Cardiovascular Angiography and Interventions (SCAI) in partnership with the American College of Cardiology (ACC).

"Acute myocardial infarction is a major medical problem, and the present study will help to define the optimal treatment strategy," said Julinda Mehilli, MD, an associate professor and staff cardiologist at Deutsches Herzzentrum, Technical University, Munich, Germany. "Therapy without abciximab would certainly be more cost-effective and reduce the risk of bleeding complications."

For the study Dr. Mehilli and colleagues recruited 800 patients with STEMI who were undergoing PCI. All patients were pretreated with 600 mg of clopidogrel and then randomly assigned to receive intravenous abciximab or a placebo during the procedu
'/>"/>

SOURCE SCAI-ACCi2
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Replikins LLC Finds West Nile Virus Replikin Count Has Reached Its Highest Recorded Value
2. Experts Call for Widespread Use of Memory Screenings and Emphasize Value of Early Detection of Dementia
3. TorreyPines Therapeutics Announces Strategic Plan with Focus on Clinical Development Activities to Maximize Value of Versatile Lead Compounds
4. Industry Executives Finding Value in Shift of Scientific Publications
5. Bertrand Study Finds Significant Value in Breast-Specific Gamma Imaging (BSGI) as an Adjunctive Procedure in Breast Diagnostics
6. Many Heart Attack Patients Dont Get Best Emergency Treatment
7. The Heart, Diabetes, And Weight Loss Centers of New York Introduce the New Science of Metabolic Diagnosis and Weight Management
8. American Heart Association Comment Saving Lives in Type 2 Diabetics: Could It Be as Easy as Lowering Blood Pressure?
9. Terumo Heart to Announce Results of European Clinical Trial of DuraHeart(TM) LVAS at European Association of Cardiothoracic Surgeons Meeting in September
10. WorldHeart Announces Further Milestone in Miniaturized Assist Pump Development
11. CellCyte Genetics Corp. Enters Collaborative Research Agreement With Cleveland Clinic Foundation to Qualify Stem Cell Delivery in Damaged Heart Tissue
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)...   Assurex Health, a personalized medicine company ... for behavioral health and chronic pain conditions, today ... equity financing from new and existing investors, according ... Chief Executive Officer. The financing will ... Health,s GeneSight ®  products.  GeneSight,s patented ...
(Date:12/24/2014)... RALEIGH, N.C. , Dec. 23, 2014 ... plc (NASDAQ: ENDP ) (TSX: ENL), and ... announced today that they have submitted a New Drug ... U.S. Food and Drug Administration (FDA).  Buprenorphine HCl Buccal ... severe enough to require daily, around-the-clock, long-term opioid treatment ...
(Date:12/22/2014)... 22, 2014 Research and Markets ( ... "US Self-monitoring Blood Glucose Market" report to their ... This market insight focuses on the developments in ... United States . Reimbursement analysis and the effects ... for more than 73 SMBG meters have been performed, ...
Breaking Medicine Technology:Assurex Health Secures $30 Million Financing Round to Continue Growth in Neuropsychiatric Pharmacogenomics 2Assurex Health Secures $30 Million Financing Round to Continue Growth in Neuropsychiatric Pharmacogenomics 3Assurex Health Secures $30 Million Financing Round to Continue Growth in Neuropsychiatric Pharmacogenomics 4Endo Pharmaceuticals and BioDelivery Sciences Announce NDA Submission for Buprenorphine HCl Buccal Film for the Management of Moderate to Severe Chronic Pain 2Endo Pharmaceuticals and BioDelivery Sciences Announce NDA Submission for Buprenorphine HCl Buccal Film for the Management of Moderate to Severe Chronic Pain 3Endo Pharmaceuticals and BioDelivery Sciences Announce NDA Submission for Buprenorphine HCl Buccal Film for the Management of Moderate to Severe Chronic Pain 4Endo Pharmaceuticals and BioDelivery Sciences Announce NDA Submission for Buprenorphine HCl Buccal Film for the Management of Moderate to Severe Chronic Pain 5US Self-monitoring Blood Glucose Market 2
... In strong collaboration with clinical research partners, Hocoma recently ... LokomatPro that offers greater system capabilities. Since the launch ... LokomatPro has established itself as an effective intervention for ... and injuries resulting in gait impairment. ...
... of a clinical research study at Sharp Memorial Hospital indicate ... functional recovery, survival and quality of life at ... for heart failure.  The study was released in the June ... of Cardiology. (Photo: http://photos.prnewswire.com/prnh/20110628/LA27443 ) ...
Cached Medicine Technology:Hocoma Launches New Version of its Established Gait Training Device LokomatPro 2New Study Shows Viability of Heart Pumps for Older Heart-Failure Patients 2New Study Shows Viability of Heart Pumps for Older Heart-Failure Patients 3
(Date:12/25/2014)... -- Overeating is common during the holidays, but there are ... says. "Don,t arrive at a party hungry. It may ... be attending a party, but deprivation leads to hunger, and ... Westchester Hospital in Mount Kisco, N.Y., said in a hospital ... day and even to have a snack before attending a ...
(Date:12/25/2014)... Dennis Thompson HealthDay ... Researchers could be closing in on a "fountain of youth" ... the health of older adults, a new study suggests. ... given a drug that targets a genetic signaling pathway linked ... Novartis report. The experimental medication, a version ...
(Date:12/25/2014)... York, New York (PRWEB) December 25, 2014 ... ) continue to move forward in a number of ... District of West Virginia, Bernstein Liebhard LLP reports. According ... Court is scheduled to convene a Joint Status Conference ... at 10:00 a.m. Parties have been directed to submit ...
(Date:12/25/2014)... 25, 2014 Plugin creators from Pixel ... A fully customizable business presentation tool made specifically for ... ProFire 5k business tool, users can now display their ... of Pixel Film Studios. “ProFire 5k gives users a ... add professionalism to a presentation” , Pixel Film Studios ...
(Date:12/25/2014)... 2014 Each year trauma accounts for ... hospital admissions across the nation (according to the ... CDC’s National Hospital Ambulatory Medical Care Survey collected ... in 2010. They estimated that there were between 3.5 ... a primary diagnosis of broken bone or fracture. ...
Breaking Medicine News(10 mins):Health News:Researchers Take 'First Baby Step' Toward Anti-Aging Drug 2Health News:Researchers Take 'First Baby Step' Toward Anti-Aging Drug 3Health News:Federal Court Overseeing Thousands of Transvaginal Mesh Lawsuits Set to Convene Joint Status Conference for All Litigations, Bernstein Liebhard LLP Reports 2Health News:Federal Court Overseeing Thousands of Transvaginal Mesh Lawsuits Set to Convene Joint Status Conference for All Litigations, Bernstein Liebhard LLP Reports 3Health News:Federal Court Overseeing Thousands of Transvaginal Mesh Lawsuits Set to Convene Joint Status Conference for All Litigations, Bernstein Liebhard LLP Reports 4Health News:Announcing a new ProFire 5k plugin from Pixel Film Studios for Final Cut Pro X Professionals 2Health News:Every Year Four Million Emergency Department Visits Result from Accidents Involving Bone Trauma 2Health News:Every Year Four Million Emergency Department Visits Result from Accidents Involving Bone Trauma 3Health News:Every Year Four Million Emergency Department Visits Result from Accidents Involving Bone Trauma 4
... continues between Israelis and Palestinians, a new University of ... inflicting on the region,s children. Palestinian and Israeli ... violence, they are also being psychologically scarred by the ... study, presented earlier this summer at the International Society ...
... intestine provide the environmental trigger that initiates and perpetuates ... to inflammatory bowel disease (IBD), a study led by ... Inflammatory bowel disease results from a loss of ... microbes that inhabit the intestine. "In this study, we ...
... as a sort of fertilizer that feeds breast ... in animal models, researchers at UCLA,s Jonsson Comprehensive ... is biologically reprogramming the immune cells that are ... from soldiers protecting the body against disease into ...
... Journal of Sexual Medicine reveals that women with low ... placebo. , Andrea Bradford, Ph.D., a psychologist at Baylor College ... University of Texas at Austin, analyzed the behaviors and symptoms ... in a large clinical trial of a drug treatment for ...
... , WEDNESDAY, Sept. 15 (HealthDay News) -- In ongoing early ... toward reducing the tell-tale inflammatory impact of the deadly bone ... drug -- called INCB018424 -- shows promise are reported in ... of Medicine . "The problem with myelofibrosis is the ...
... 14, 2010) A new investigational drug designed to penetrate ... patient for the first time ever at the Virginia G. ... a potent, targeted compound designed to selectively kill cancer cells, ... Phase I clinical trial. Pancreatic cancer is a fast-growing and ...
Cached Medicine News:Health News:Study: How Palestinian and Israeli children are psychologically scarred by exposure to war 2Health News:Study: How Palestinian and Israeli children are psychologically scarred by exposure to war 3Health News:Bacteria identified that may lead to inflammatory bowel disease in certain individuals 2Health News:Stress accelerates breast cancer progression in mice 2Health News:Stress accelerates breast cancer progression in mice 3Health News:Stress accelerates breast cancer progression in mice 4Health News:Experimental Drug Shows Promise for Bone Marrow Disorder 2Health News:Experimental Drug Shows Promise for Bone Marrow Disorder 3Health News:New investigational compound targets pancreatic cancer cells 2
... easy to operate and maintain. The units ... flexible snap-seal pockets which minimize the potential ... the water. Offered in two-, four-, and ... bags of various sizes. ThermoLine Thawing Systems ...
Conventional Digitally-Controlled Water Baths...
Dry thaws. Has an ingenious (pat. pending) massaging sytem that utilizes the tempered bladders as hands. There are no unreliable mechanical parts involved. Two pumps pressurize different segments of ...
... of two principal components. The AB5000 Console is ... pumps and can be used either in the ... The AB5000 Ventricle is a disposable blood pump ... ventricles of the heart and is designed to ...
Medicine Products: